Preclinical toxicity studies supporting 2DG for treatment of status epilepticus.
Saved in:
| Title: | Preclinical toxicity studies supporting 2DG for treatment of status epilepticus. |
|---|---|
| Authors: | Sutula TP; Department of Neurology, University of Wisconsin, Madison WI, USA; Hexokine Therapeutics, Inc. Madison WI, USA. Electronic address: sutula@neurology.wisc.edu., Fountain NB; Department of Neurology, F.E. Dreifuss Comprehensive Epilepsy Program, University of Virginia, Charlottesville VA, USA; Hexokine Therapeutics, Inc. Madison WI, USA. |
| Source: | Epilepsy & behavior : E&B [Epilepsy Behav] 2024 Nov; Vol. 160, pp. 110004. Date of Electronic Publication: 2024 Sep 05. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 100892858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-5069 (Electronic) Linking ISSN: 15255050 NLM ISO Abbreviation: Epilepsy Behav Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
